These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

693 related articles for article (PubMed ID: 25236865)

  • 1. Role of the breast cancer resistance protein (BCRP/ABCG2) in drug transport--an update.
    Mao Q; Unadkat JD
    AAPS J; 2015 Jan; 17(1):65-82. PubMed ID: 25236865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the breast cancer resistance protein (ABCG2) in drug transport.
    Mao Q; Unadkat JD
    AAPS J; 2005 May; 7(1):E118-33. PubMed ID: 16146333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure and function of the human breast cancer resistance protein (BCRP/ABCG2).
    Ni Z; Bikadi Z; Rosenberg MF; Mao Q
    Curr Drug Metab; 2010 Sep; 11(7):603-17. PubMed ID: 20812902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidrug resistance in cancer chemotherapy and xenobiotic protection mediated by the half ATP-binding cassette transporter ABCG2.
    Han B; Zhang JT
    Curr Med Chem Anticancer Agents; 2004 Jan; 4(1):31-42. PubMed ID: 14754410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flavonoids are inhibitors of breast cancer resistance protein (ABCG2)-mediated transport.
    Zhang S; Yang X; Morris ME
    Mol Pharmacol; 2004 May; 65(5):1208-16. PubMed ID: 15102949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer resistance protein (BCRP/ABCG2): its role in multidrug resistance and regulation of its gene expression.
    Nakanishi T; Ross DD
    Chin J Cancer; 2012 Feb; 31(2):73-99. PubMed ID: 22098950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2).
    Doyle L; Ross DD
    Oncogene; 2003 Oct; 22(47):7340-58. PubMed ID: 14576842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functions of the breast cancer resistance protein (BCRP/ABCG2) in chemotherapy.
    Noguchi K; Katayama K; Mitsuhashi J; Sugimoto Y
    Adv Drug Deliv Rev; 2009 Jan; 61(1):26-33. PubMed ID: 19111841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of breast cancer resistance protein (BCRP/ABCG2)-mediated drug resistance by novobiocin, a coumermycin antibiotic.
    Shiozawa K; Oka M; Soda H; Yoshikawa M; Ikegami Y; Tsurutani J; Nakatomi K; Nakamura Y; Doi S; Kitazaki T; Mizuta Y; Murase K; Yoshida H; Ross DD; Kohno S
    Int J Cancer; 2004 Jan; 108(1):146-51. PubMed ID: 14618629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gefitinib ("Iressa", ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor, reverses breast cancer resistance protein/ABCG2-mediated drug resistance.
    Nakamura Y; Oka M; Soda H; Shiozawa K; Yoshikawa M; Itoh A; Ikegami Y; Tsurutani J; Nakatomi K; Kitazaki T; Doi S; Yoshida H; Kohno S
    Cancer Res; 2005 Feb; 65(4):1541-6. PubMed ID: 15735043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer resistance protein exports sulfated estrogens but not free estrogens.
    Imai Y; Asada S; Tsukahara S; Ishikawa E; Tsuruo T; Sugimoto Y
    Mol Pharmacol; 2003 Sep; 64(3):610-8. PubMed ID: 12920197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C.
    Allen JD; van Loevezijn A; Lakhai JM; van der Valk M; van Tellingen O; Reid G; Schellens JH; Koomen GJ; Schinkel AH
    Mol Cancer Ther; 2002 Apr; 1(6):417-25. PubMed ID: 12477054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance.
    Natarajan K; Xie Y; Baer MR; Ross DD
    Biochem Pharmacol; 2012 Apr; 83(8):1084-103. PubMed ID: 22248732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Marine natural products as breast cancer resistance protein inhibitors.
    Cherigo L; Lopez D; Martinez-Luis S
    Mar Drugs; 2015 Apr; 13(4):2010-29. PubMed ID: 25854646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Pyrazolo[3,4-d]pyrimidine Derivative, SCO-201, Reverses Multidrug Resistance Mediated by ABCG2/BCRP.
    Ambjørner SEB; Wiese M; Köhler SC; Svindt J; Lund XL; Gajhede M; Saaby L; Brodin B; Rump S; Weigt H; Brünner N; Stenvang J
    Cells; 2020 Mar; 9(3):. PubMed ID: 32143347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan.
    Jonker JW; Smit JW; Brinkhuis RF; Maliepaard M; Beijnen JH; Schellens JH; Schinkel AH
    J Natl Cancer Inst; 2000 Oct; 92(20):1651-6. PubMed ID: 11036110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developing multidrug-resistant cells and exploring correlation between BCRP/ABCG2 over-expression and DNA methyltransferase.
    Ji N; Yuan J; Liu J; Tian S
    Acta Biochim Biophys Sin (Shanghai); 2010 Dec; 42(12):854-62. PubMed ID: 21106767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical interaction of anti-HCV telaprevir with the ABC transporters P-glycoprotein and breast cancer resistance protein.
    Fujita Y; Noguchi K; Suzuki T; Katayama K; Sugimoto Y
    BMC Res Notes; 2013 Nov; 6():445. PubMed ID: 24196382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of the ATP-binding cassette half-transporter, ABCG2 (Mxr/BCrp/ABCP1), in flavopiridol-resistant human breast cancer cells.
    Robey RW; Medina-Pérez WY; Nishiyama K; Lahusen T; Miyake K; Litman T; Senderowicz AM; Ross DD; Bates SE
    Clin Cancer Res; 2001 Jan; 7(1):145-52. PubMed ID: 11205902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of the activity and substrate recognition of breast cancer resistance protein (ABCG2).
    Szafraniec MJ; Szczygieł M; Urbanska K; Fiedor L
    Drug Metab Rev; 2014 Nov; 46(4):459-74. PubMed ID: 25036722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.